Correction: Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison.
Saved in:
| Title: | Correction: Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison. |
|---|---|
| Authors: | Mease PJ; Swedish Medical Center/Providence St. Joseph Health, and University of Washington, Seattle, WA, USA., Warren RB; Dermatology Centre, Northern Care Alliance NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK., Nash P; School of Medicine, Griffith University School of Medicine, Brisbane, QLD, Australia., Grouin JM; University of Rouen, Rouen, France., Lyris N; UCB Pharma, Slough, UK., Willems D; UCB Pharma, Brussels, Belgium., Taieb V; UCB Pharma, Colombes, France., Eells J; UCB Pharma, Slough, UK., McInnes IB; College of Medical, Veterinary and Life Sciences, University of Glasgow, Wolfson Medical School Building, University Avenue, Glasgow, G12 8QQ, UK. Iain.McInnes@glasgow.ac.uk. |
| Source: | Rheumatology and therapy [Rheumatol Ther] 2026 Jun; Vol. 13 (3), pp. 881-884. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Springer Healthcare Country of Publication: England NLM ID: 101674543 Publication Model: Print Cited Medium: Print ISSN: 2198-6576 (Print) Linking ISSN: 21986576 NLM ISO Abbreviation: Rheumatol Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2198-6576 |
|---|---|
| DOI: | 10.1007/s40744-026-00831-8 |
